Advertisement

Neuroblastoma

  • Odile Schweisguth

Abstract

Of the malignant tumors in children, neuroblastoma is one in which no substantial therapeutic progress has been made in recent years. However, the unpredictability of its course and the possible contribution of immunological processes to its clinical course make it a fascinating disease.

Keywords

Metastatic Bone Disease Intravenous Pyelogram Vanillyl Mandelic Acid Vincristine Sulfate Metastatic Neuroblastoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    VIEU, F.: Contribution a l’étude de l’anemie du neuroblastome de l’enfant. Thése Universite; Paris Sud, 1971.Google Scholar
  2. 2.
    LEPINTRE, J., SCHWEISGUTH, O.. LABRUNE, M. and LEMERLE, J.: Les neuro-blastomes en sablier. Etude de 22 cas. Arch Fr Pediatr, 26: 829, 1969.PubMedGoogle Scholar
  3. 3.
    PEPPER, W.: A study of congenital sarcoma of the liver and suprarenal. Am J Med Sci, 121: 287, 1901.CrossRefGoogle Scholar
  4. 4.
    BOHUON, C.. ed: Neuroblastomas — Biochemical Studies. In: Recent Results in Cancer Research, Vol. 2, New York, Springer-Verlag, 1966.Google Scholar
  5. 5.
    LABROSSE, E. H.. Catechol-0-methyltransferase activity in neuroblastoma tumour. Nature, 196: 1222, 1962.PubMedCrossRefGoogle Scholar
  6. 6.
    EVANS, A. E., BLORE, J., HADLEY R. and TANINDI, S.: The Las Brosse spot test: A practical aid in the diagnosis and management of children with neuroblastoma. Pediatrics, 47: 913, 1971.PubMedGoogle Scholar
  7. 7.
    GITLOW, S. E., BERTANI, L. M., RAUSEN, A., GRIBETZ, D. and DZIEDZIC, S. W.: Diagnosis of neuroblastoma by qualitative and quantitative determination of catecholamine metabolites in urine. Cancer, 25: 1377, 1970.PubMedCrossRefGoogle Scholar
  8. 8.
    GEISER, C. F. and EFRON, M. L.: Cystathioninuria in patients with neuroblastoma or ganglioneuroblastoma. Its correlation to vanilmandelic acid excretion and its value in diagnosis and therapy. Cancer, 22: 856, 1968.PubMedCrossRefGoogle Scholar
  9. 9.
    STUDNITZ, W. von: Cystathioninuria in children with neuroblastoma with and without metastasis. Acta Paediatr Scand, 59: 80, 1970.CrossRefGoogle Scholar
  10. 10.
    STUDNITZ, W. von: Homoserine in urine in patients with neuroblastoma. Scand J Clin Lab Invest, 17: 558, 1965.CrossRefGoogle Scholar
  11. 11.
    STUDNITZ, W. von and HANSON, A.: Demonstration of urinary N-acetyltyramine in patients with neuroblastoma. Clin Chim Acta, 16: 180, 1967.CrossRefGoogle Scholar
  12. 12.
    GREEN, M., COOKE, R. E. and LATTANZI, W.: Occurrence of chronic diarrhea in three patients with ganglioneuromas. Pediatrics, 23: 951, 1959.PubMedGoogle Scholar
  13. 13.
    STICKLER, G. B., HALLENBECK, G. A., FLOCK, E. V. and ROSEVEAR, J. W.: Ganglioneuroblastoma and diarrhea. Am J Dis Child, 104: 598, 1962.PubMedGoogle Scholar
  14. 14.
    KENNY, F. M., STAVRIDES, A., VOORHESS, M. L. and KLEIN, R.: Cushing’s syndrome associated with an adrenal neuroblastoma. A case in an infant with clinical, pathological, and adrenal cortical and medullary hormone excretion studies. Am J Dis Child, 113: 611, 1967.PubMedGoogle Scholar
  15. 15.
    KOGUT, M. D. and DONNELL, G: N.. Cushing’s syndrome in association with renal ganglioneuroblastoma. Pediatrics, 28: 566, 1961.PubMedGoogle Scholar
  16. 16.
    NORMANN, T., HAUNEN, J. and MJOLNEROD, O.: Cushing’s syndrome in an infant associated with neuroblastoma in two ectopic adrenal glands. J Pediatr Surg, 6: 197, 1971.CrossRefGoogle Scholar
  17. 17.
    FOURNIER, A., PAULI, A.. DUCOULOMBIER, H.. COUSIN, J. and CARTON, M. B.: Syndrome oculo-cerebello-myoclonique et sympathoblastome. (A propos d’une observation). Arch Fr Pediatr, 27: 766, 1970.Google Scholar
  18. 18.
    KOROBKIN, M., CLARK, R. E. and PALUBINSKAS, A. J.: Occult neuroblastoma and acute cerebellar ataxia in childhood. Radiology, 102: 151, 1972.PubMedGoogle Scholar
  19. 19.
    LARBRE, F., BETHENOD, M., GUIBAUD, P., MAMELLE, J. C. and GENOUD, J.: Syndrome oculo-cerebello-myoclonique et neuroblastome. A propos de deux observations. Arch Fr Pediatr, 29: 421, 1972.Google Scholar
  20. 20.
    LEMERLE, J., LEMERLE, M., AICARDI, J., MESSICA, C. and SCHWEISGUTH, O.: Trois cas d’association à un neuroblastome d’un syndrome oculo-cerebellomyoclonique. Arch Fr Pediatr, 26: 547, 1969.PubMedGoogle Scholar
  21. 21.
    LEONIDAS, J. C., BRILL, C. B. and ARON, A.M.: Neuroblastoma presenting with myoclonic encephalopathy. Radiology, 102: 87, 1972.PubMedGoogle Scholar
  22. 22.
    MARTIN, E. S.. GRIFFITH, J. F. and DURHAM, N. C.: Myoclonic encephalopathy and neuroblastoma. Am J Dis Child, 122: 257, 1971.Google Scholar
  23. 23.
    MOE, P. G. and NELLHAUS, G.: Infantile polymyoclonia-opsoclonuc syndrome and neural crest tumors. Neurology (Minneap), 20: 756, 1970.Google Scholar
  24. 24.
    EVANS, A. E., D’ANGIO, G. J. and RANDOLPH, J.: A proposed staging for children with neuroblastoma. Cancer, 27: 374, 1971.Google Scholar
  25. 25.
    KOOP, C. E. and JOHNSON, D. G.: Neuroblastoma: An assessment of therapy in reference to staging. JPediatr Surg, 6: 595, 1971.CrossRefGoogle Scholar
  26. 26.
    EVANS, A. E., HEYN, R. M.. NEWTON, W. A. and LEIKIN, S. L.: Vincristine sulfate and cyclophosphamide. JAMA, 207: 1325, 1969.Google Scholar
  27. 27.
    PINKEL, D., PRATT, C., HOLTON, C., JAMES, D., WRENN, E. and HUSTU, O.: Survival of children with neuroblastoma treated with combination therapy. J Pediatr, 73: 928, 1968.PubMedCrossRefGoogle Scholar
  28. 28.
    SAWITSKY, A., et al.. Vincristine and cyclophosphamide therapy on generalized neuroblastoma: A collaborative study. Am J Dis Child, 119: 308, 1970.Google Scholar
  29. 29.
    WINDMILLER, J., BERRY, D. H. HADDY, T. B., VIETTI, T. J. and SUTOW, W. W.: Vincristine sulfate in the treatment of neuroblastoma in children. Am J Dis Child, 111: 75, 1966.Google Scholar
  30. 30.
    FERNBACH, D. J., HADDY, T. B. HOLCOMB, T. M., STUCKEY, W. J., SULLIVAN, M. P. and WATKINS, W. L.: L-Sarcolysin (NSC-8806) therapy for children with metastatic neuroblastoma. Cancer Chemother Rep, 52: 293, 1968.PubMedGoogle Scholar
  31. 31.
    FERNBACH, D. J., HADDY, T. B., HOLCOMB, T. M., LUSHER, J., SUTOW, W. W. and VIETTI, T. J.: Uracil mustard (NSC-34462) therapy for children with metastatic neuroblastoma. Cancer Chemother Rep, 52: 287, 1968.PubMedGoogle Scholar
  32. 32.
    SAMUELS, L. D., NEWTON, W. A. and HEYN, R.: Daunorubicin therapy in advanced neuroblastoma. Cancer, 27: 831, 1971.PubMedCrossRefGoogle Scholar
  33. 33.
    SUTOW, W. W., FERNBACH, D. J., THURMAN, W. G., HOLTON, C. P. and WATKINS, W. L.: Daunomycin in the treatment of metastatic neuroblastoma. Cancer Chemother Rep, 54: 283, 1970.Google Scholar
  34. 34.
    BODIAN, M.: Neuroblastoma. Pediatr Clin North Am, 6: 449, 1959.Google Scholar
  35. 35.
    VOGEL, J. M., CODDON, D. R., SIMON, N. and GITLOW, S. E.: Osseous metastases in neuroblastoma. A 17-year survival. Cancer, 26: 1354, 1970.PubMedCrossRefGoogle Scholar
  36. 36.
    GOLDMAN, R. L., WINTERLING, A. N. and WINTERLING, C. C.: Maturation of tumours of the sympathetic nervous system. Report of long term survival in two patients, one with disseminated osseous metastases, and review of cases from the literature. Cancer, 18: 1510, 1965.PubMedCrossRefGoogle Scholar
  37. 37.
    BILL, A. H. and MORGAN, A.: Evidence for immune reactions to neuroblastoma and future possibilities for investigation. JPediatr Surg, 5: 111, 1970.CrossRefGoogle Scholar
  38. 38.
    HELLSTROM, I. E., HELLSTROM, K. E., PIERCE, G. E. and BILL, A. H.: Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Nall Acad Sci USA, 60: 1231, 1968.CrossRefGoogle Scholar
  39. 39.
    KUMAR, S., STEWARD, J. K., WAGHE, M., PEARSON, D. EDWARDS, D. C., FENTON, E. L. and GRIFFITH, A. H.: The administration of the nerve growth factor to children with widespread neuroblastoma. JPediatr Surg, 5: 18, 1970.CrossRefGoogle Scholar
  40. 40.
    ANGELETTI, P. U. and LEVI-MONTALCINI, R.: Cytolytic effect of 6-hydroxydopamine on neuroblastoma cells. Cancer Res, 30: 2863, 1970.PubMedGoogle Scholar

Copyright information

© Ontario Cancer Treatment and Research Foundation 1973

Authors and Affiliations

  • Odile Schweisguth
    • 1
  1. 1.Service de PediatrieInstitut Gustave-RoussyVillejuifFrance

Personalised recommendations